Stockholders Approve 1-for-25 Reverse Split to Maintain NYSE Listing
AGL sits 56% above its 52-week low of $0.338 on light trading volume (0.3× avg).
Summary
agilon health stockholders approved a reverse stock split, with the Board subsequently setting a 1-for-25 ratio, primarily to regain compliance with NYSE minimum bid price requirements and avoid delisting.
Key Events · Corporate Governance and Compliance · AGL
-
Reverse Stock Split Approved
Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split with a ratio between 1-for-5 and 1-for-25.
-
1-for-25 Ratio Set
The Board of Directors subsequently approved the implementation of a 1-for-25 reverse stock split.
-
NYSE Listing Compliance
The primary purpose of the reverse split is to increase the stock price above $1.00 to comply with NYSE minimum bid price requirements and avoid delisting.
-
Effective Date
The reverse stock split is expected to become effective on March 30, 2026, with trading on a split-adjusted basis beginning March 31, 2026.
Analysis · AGL · Industrial Applications And Services
This reverse stock split is a critical step for agilon health to address its ongoing NYSE delisting threat, as previously indicated in its recent 10-K filing. While reverse splits do not change a company's fundamental value, this action is necessary to maintain the company's listing on a major exchange, which is crucial for liquidity and investor access. The 1-for-25 ratio is substantial, aiming to significantly boost the per-share price above the $1.00 minimum. Investors should monitor the stock's performance post-split and the company's ability to sustain the higher price.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1052 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AGL was trading at $0.53 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $244.8M. The 52-week trading range was $0.34 to $6.08. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.